Use of recombinant herpes simplex virus type 1 vectors for gene transfer into tumour and normal anterior pituitary cells

Molecular and Cellular Endocrinology

Volumn 139, Issue 1-2, 1998, Pages 199-207

  Goya, Rodolfo G ^a   Rowe, Joanna ^a   Sosa, Yolanda E ^a   Tomasec, Peter ^a   Lowenstein, Pedro R ^a   Castro, Maria G ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Anterior pituitary cells; Gene transfer; Herpes simplex type 1

Indexed keywords

BETA GALACTOSIDASE; CORTICOTROPIN; TISSUE INHIBITOR OF METALLOPROTEINASE;

ADENOHYPOPHYSIS; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; EXPRESSION VECTOR; GENE EXPRESSION; GENE TRANSFER; HERPES SIMPLEX VIRUS 1; HYPOPHYSIS TUMOR; IMMUNOFLUORESCENCE TEST; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REPORTER GENE; TRANSGENE; VIRUS RECOMBINANT;

ANIMALS; BETA-GALACTOSIDASE; BLOOD; CELL DIVISION; CELLS, CULTURED; CORTICOTROPIN-RELEASING HORMONE; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; HERPESVIRUS 1, HUMAN; MALE; MICE; PITUITARY GLAND, ANTERIOR; PITUITARY NEOPLASMS; RATS; RATS, WISTAR; RECOMBINANT FUSION PROTEINS; TISSUE INHIBITOR OF METALLOPROTEINASES; TRANSGENES; TUMOR CELLS, CULTURED;

EID: 0032580270     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(98)00059-8     Document Type: Article

References (23)

1. Breakfield X.O., De Luca N.A. Herpes simplex virus for gene delivery to neurons. New Biol. 3:1991;203-218.
2. Brown O.A., Santer R.M., Shering A.F., Larregina A.T., Morelli A.E., Southgate T.D., Castro M.G., Lowenstein P.R. Gene transfer into enteric neurons of the rat intestine in organ culture using a replication defective recombinant herpes virus type 1 (HSV-1) vector, but not recombinant adenovirus vectors. Gene Ther. 4:1997;331-338.
3. Castro M.G., Gusovsky F., Loh Y.P. Transmembrane signals mediating adrenocorticotropin release from mouse anterior pituitary cells. Mol. Cell. Endocrinol. 65:1989;165-173.
4. Geller A.I., Freese A. Infection of cultured central nervous system neurons with a defective herpes simplex virus 1 vector results in stable expression of Escherichia coli β-galactosidase. Proc. Natl. Acad. Sci. USA. 87:1990;1149-1153.
5. Geller A.I., During M.J., Neve R.L. Molecular analysis of neuronal physiology of gene transfer into neurons with herpes simplex virus vectors. Trends Neurosci. 14:1991;428-432.
6. Glorioso J.C., Goins W.F., Fink D.J. Herpes simplex virus-based vectors. Semin. Virol. 3:1992;265-276.
7. Johnson P.A., Miyanohara A., Levine F., Cahill T., Friedmann T. Cytotoxicity of replication-defective mutant of herpes simplex virus type 1. J. Virol. 66:1992;2952-2965.
8. Johnson P.A., Wang M.J., Friedmann T. Improved cell-survival by the reduction of immediate-early gene-expression in replication-defective mutants of herpes simplex virus type-1 but not by mutation of the virion shutoff function. J. Virol. 68:1994;6347-6362.
9. Kaplitt, M.G., Loewy, A.D., 1995. Viral Vectors Gene Therapy and Neuroscience Applications. Academic Press, New York.
10. Lowenstein P.R., Enquist L.W. Protocols for gene transfer. Lowenstein P.R., Enquist L. Neuroscience Towards Gene Therapy of Neurological Disorders. 1995;417, Wiley, Chichester.
11. Lowenstein P.R., Morrison E.E., Bain D., Hodge P., Preston C.M., Clissold P., Stow N.D., McKee T.A., Castro M.G. Use of recombinant vectors derived from herpes simplex virus 1 mutant tsK for short-term expression of transgenes encoding cytoplasmic and membrane anchored proteins in postmitotic polarized cortical neurons and glial cells in vitro. Neuroscience. 60:1994;1059-1077.
12. Lowenstein P.R., Fournel S., Bain D., Tomasec P., Clissold P., Castro M.G., Epstein A.L. Herpes simplex virus 1 (HSV-1) helper co-infection of an amplicon encoded protein in glia. Neuroreport. 5:1994;1625-1630.
13. MacGregor G.R., Nolan G.P., Fiering S., Roederer M., Herzenberg L.A. Use of E. coli lac Z (β-galactosidase) as a reporter gene. Murray E.J. Methods in Molecular Biology: Gene Transfer and Expression Protocols. 7:1991;217-235 Humana, Clifton.
14. Marsden H.S., Crombie I.K., Subak-Sharpe J.H. Control of protein synthesis in herpes-virus-infected cells: analysis of the polypeptides induced by wild-type and sixteen temperature-sensitive mutants of strain 17. J. Gen. Virol. 31:1976;347-371.
15. O'Malley B.W., Adams R.M., Sikes M.L., Sawada T., Ledley F.D. Retrovirus-mediated gene-transfer into canine thyroid using an ex vivo strategy. Hum. Gene Ther. 4:1993;171-178.
16. O'Malley B.W., Adams R.M., Sikes M.L., Ledley F.D. Gene-transfer into human thyroid follicular cells. Laryngoscope. 104:1994;1330-1336.
17. Preston C.M. Control of herpes simplex virus type 1 mRNA synthesis in cells infected with wild-type virus or the temperature-sensitive mutant tsK. J. Virol. 29:1979;275-284.
18. Shering A.F., Bain D., Stewart K., Epstein A.L., Castro M.G., Wilkinson G.W.G., Lowenstein P.R. Cell type specific expression in brain cell cultures from a short human cytomegalovirus major immediate early promoter depends on whether it is expressed from herpesvirus or adenovirus vectors. J. Gen. Virol. 78:1997;445-459.
19. Sikes M.L., O'Malley B.W., Finegold M.J., Ledley F.D. In vivo gene transfer into rabbit thyroid follicular cells by direct DNA injection. Hum. Gene Ther. 5:1994;837-844.
20. Stewart C., Taylor N.A., Docherty K., Bailey C.J. Insulin delivery by somatic cell gene therapy. J. Mol. Endocrinol. 11:1993;335-341.
21. Tomasec P., Bain D., Castro M.G., Preston C.M., Lowenstein P.R. Herpes simplex virus temperature-sensitive mutant tsK as a vector for neuronal gene transfer. Lowenstein P.R., Enquist L.W. Protocols for Gene Transfer in Neuroscience: Towards Gene Therapy of Neurological Disorders. 1996;169-186 Wiley, Chichester.
22. Watson R.J., Clements J.B. A herpes simplex virus type 1 function required for early and late virus RNA synthesis. Nature. 285:1980;329-330.
23. Wu N., Watkins S.C., Schaffer P.A., DeLuca N.A. Prolonged gene expression and cell survival after infection by a HSV-1 mutant defective in the immediate early genes encoding ICP4, ICP27 and ICP22. J. Virol. 70:1996;6358-6369.